FIELD: medicine, oncogynecology. SUBSTANCE: method involves the additional use of anticoagulating agent and aspirin at mean therapeutic doses in combination with the known method of treatment by hormonal therapy with synthetic progestines. Method can be used for treatment of patients with endometrium cancer. EFFECT: enhanced effectiveness of treatment. 2 tbl
Authors
Dates
1998-05-20—Published
1992-12-21—Filed